VMD in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with VMD today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Viemed Healthcare, Inc. helps patients with chronic respiratory conditions receive treatment at home. It supplies ventilators and related equipment, while licensed respiratory therapists set up equipment, train patients and provide on-call support. Ventilator rentals generate most of its revenue. The company also provides other home medical equipment and supplies, women’s health products and services, and staffing for healthcare facilities.
Medicare is its largest individual payor; private insurers and other healthcare programs also reimburse its services. Much of its revenue follows payment rates set by the Centers for Medicare & Medicaid Services, so the business depends on insurance coverage, reimbursement rates and timely payment—not just patient demand. Medicare coverage for home ventilation requires patients to meet medical-necessity criteria. Viemed must also maintain state medical-equipment supplier licenses and the accreditation many payors require to remain eligible to provide services and collect reimbursement.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Viemed Healthcare, Inc.’s results hinge on home ventilator patient growth and reimbursement rates set by CMS, while Lincare and Quipt Home Medical are important home respiratory competitors missing from this list.
AdaptHealth Corp. competes with Viemed Healthcare, Inc. for patients referred for home respiratory care, providing ventilation, oxygen and sleep-apnea equipment and services. Its Respiratory Health and Sleep Health results are worth watching for signs of demand in the home-care businesses they share.
Inogen Inc’s direct sales and rentals of portable equipment that supplies oxygen compete with Viemed Healthcare, Inc.’s home oxygen offerings, though ventilator rentals are Viemed’s largest business. Watch Inogen’s direct-to-consumer sales and rentals for signs of competition for oxygen patients, rather than as a readout of Viemed’s core ventilation business.
AdaptHealth Corp. earningsAHCO
AdaptHealth’s Respiratory Health and Sleep Health results will show whether demand is strengthening across the home-care businesses it shares with Viemed or moving unevenly.
Read AdaptHealth’s Respiratory Health and Sleep Health results together. Growth in both would point to broader demand across shared home-care markets, where referred patients may need both respiratory and sleep-related equipment and services. If Sleep Health grows while Respiratory Health weakens, demand is uneven and does not confirm strength in Viemed’s ventilator market. The results will show whether demand is spreading across the shared market or concentrated in only part of it.
Viemed Healthcare, Inc. earningsThis company
Viemed Healthcare’s report will show whether ventilator rentals keep growing enough to offset the margin pressure from expanding equipment and supply sales.
Read ventilator-rental revenue alongside gross margin, and include ventilator patient numbers if the company reports them. Rising rental revenue and patient numbers with a steady margin would show the recurring business is expanding without a marked shift toward lower-margin sales. If total revenue grows mainly through equipment and supply sales while gross margin falls, the added revenue is bringing in less gross profit. The results will show whether growth rests on core rentals or relies more on higher-cost sales.